摘要
目的:让中医药专业人员能更清楚理解、识别并正确使用桑寄生与槲寄生,以取得良好的临床疗效。方法:从历代本草文献及现代药典标准角度考察分析其药用历史沿革,以正本清源。分析历代本草相关记述、化学成分、药理作用及临床应用等内容,综合认识二者来源、性状特征以及功效的异同。结果:从本草考证结合药典标准来看原桑(上)寄生实指今槲寄生,主产我国北方及中部地区,现桑寄生实为同科不同种的另一种(类)半寄生植物广寄生,主产两广及云南。结论:从历史沿革来看桑寄生之名其实更应该属于现在药典之槲寄生,药典之桑寄生建议更名为寄生或广寄生。
Objective: To enable Chinese medicine professionals to better understand, recognize and correctly use Sangjisheng and Hujisheng for good clinical efficacy. Method: The medicinal history was analyzed from the perspective of historical documents and modern Pharmacopoeia standards. The related descriptions, chemical constituents, pharmacological effects and clinical applications of ancient herbs were analyzed to comprehensively understand the similarities and differences of the source, characteristics and efficacy of Sangjisheng and Hujisheng. Result: From the perspective of Materia Medica combined with pharmacopoeia standards, the original Sangjisheng in ancient time was actually Hujisheng at the modern time, which was mainly produced in the northern and central regions of China. Sanjisheng at the modern time was another kind of semi-parasitic plants of different specie of the same family, which was mainly produced in the main production of Guangdong, Guangxi and Yunnan. Conclusion: The name of Sangjisheng belongs to Hujisheng in the current Pharmacopoeia. The recommendation of Sangjisheng of the Pharmacopoeia is recommended to be renamed as jisheng or Guangjisheng.
作者
杨晓东
刘兴文
李福兵
胡晓莉
YANG Xiao-dong;LIU Xing-wen;LI Fu-bing;HU Xiao-li(Chongqing Beibei District Hospital of Traditional Chinese Medicine, Beibei 400700, Chongqing)
出处
《中药与临床》
2019年第1期39-42,共4页
Pharmacy and Clinics of Chinese Materia Medica
基金
全国中药特色技术传承人才培养项目
国家中医药管理局中药炮制技术传承基地建设项目
关键词
桑寄生
槲寄生
本草文献
Sangjisheng
Hujisheng
herbal literature
